Genetic Evaluation of Late-Onset Hypertrophic Cardiomyopathy: An Autobiographical Case Report

  • Carlo S
  • Rodríguez-Fernández L
  • Benítez Ríos F
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Cardiomyopathy, also known as a pathology with a cardiovascular cause, can be further differentiated into multiple categories including genetic. Strong correlations between genetic mutations in sarcomeric proteins and presentation of cardiomyopathies have been made. This case report describes the clinical diagnosis of my late-onset hypertrophic cardiomyopathy, which was brought upon by symptoms of chest pain and palpitations that started approximately two years ago and had mostly gone unnoticed during this period. As a geneticist, I decided to undergo genetic test upon diagnosis. These tests found a heterozygous variant of uncertain significance (VUS) in the ALPK3 gene, c.399dup (p.Gly134ArgfsTer30), and a heterozygous c.7552G>A (p.Val2518Ile) VUS in the desmoplakin (DSP) gene. This autobiographical case report hopes to shed light on the importance of genetic screening in the search for the etiology of clinical symptoms.

Cite

CITATION STYLE

APA

Carlo, S., Rodríguez-Fernández, L. F., Benítez Ríos, F. A., Arciniegas-Medina, N. J., & Martínez-González, H. (2022). Genetic Evaluation of Late-Onset Hypertrophic Cardiomyopathy: An Autobiographical Case Report. Cureus. https://doi.org/10.7759/cureus.23349

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free